Skip to content
Home/Companies/Healthcare/H2 Pharma
H2 Pharma

H2 Pharma

Healthcare·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns H2 Pharma?

H2 Pharma is currently owned by Ardian through Ardian Growth Fund II (2018 vintage), since 2020.

Hand-verified · updated 2026-04-21

Ardian
Investor
Ardian
Ardian Growth Fund II · 2018 · Growth

Key facts

HQFrance
SectorHealthcare
Websitewww.h2pharma.com

More from Ardian Growth Fund II

Other portfolio companies in the same fund.

Digital Value
Digital Value
Active
Business ServicesFrance· 2021
easiware
easiware
Active
SoftwareFrance· 2021
Elée
Active
SoftwareFrance· 2021
Jakala
Active
Business ServicesItaly· 2021
Kapten & Son
Kapten & Son
Active
ConsumerGermany· 2021
Logalty
Logalty
Active
LegalTechSpain· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track H2 Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy H2 Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on H2 Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue